Inter-conversion of neuregulin2 full and partial agonists for ErbB4

Biochemical and Biophysical Research Communications

Volumn 364, Issue 2, 2007, Pages 351-357

  Wilson, Kristy J ^a   Mill, Christopher P ^b   Cameron, Elizabeth M ^a   Hobbs, Stuart S ^a   Hammer, Robert P ^a,b   Riese II, David J ^a  

^a PURDUE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Differential efficacy; ErbB4; Neuregulin; Partial and full agonists; Signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; INTERLEUKIN 3; MUTANT PROTEIN; NEU DIFFERENTIATION FACTOR; NEUREGULIN2ALPHA; NEUREGULIN2BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY;

AMINO ACID SEQUENCE; CELL LINE; GLYCINE; HUMANS; INTERLEUKIN-3; MOLECULAR SEQUENCE DATA; MUTATION; NERVE GROWTH FACTORS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN SPLICING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; TYROSINE;

EID: 35548980450     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.004     Document Type: Article

References (23)

1. Normanno N., Bianco C., De Luca A., and Salomon D. The role of EGF-related peptides in tumor growth. Front. Biosci. 6 (2001) 685-707
2. Normanno N., Bianco C., Strizzi L., Mancino M., Maiello M.R., De Luca A., Caponigro F., and Salomon D.S. The ErbB receptors and their ligands in cancer: an overview. Curr. Drug Targets 6 (2005) 243-257
3. Strachan L., Murison J.G., Prestidge R.L., Sleeman M.A., Watson J.D., and Kumble K.D. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem. 276 (2001) 18265-18271
4. Kinugasa Y., Ishiguro H., Tokita Y., Oohira A., Ohmoto H., and Higashiyama S. Neuroglycan C, a novel member of the neuregulin family. Biochem. Biophys. Res. Commun. 321 (2004) 1045-1049
5. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 284 (2003) 14-30
6. Marchionni M.A., Goodearl A.D., Chen M.S., Bermingham-McDonogh O., Kirk C., Hendricks M., Danehy F., Misumi D., Sudhalter J., Kobayashi K., et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362 (1993) 312-318
7. Riese II D.J., and Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20 (1998) 41-48
8. Citri A., and Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7 (2006) 505-516
9. Warren C.M., and Landgraf R. Signaling through ERBB receptors: multiple layers of diversity and control. Cell Signal. 18 (2006) 923-933
10. Hobbs S.S., Coffing S.L., Le A.T., Cameron E.M., Williams E.E., Andrew M., Blommel E.N., Hammer R.P., Chang H., and Riese II D.J. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 21 (2002) 8442-8452
11. Hobbs S.S., Cameron E.M., Hammer R.P., Le A.T., Gallo R.M., Blommel E.N., Coffing S.L., Chang H., and Riese II D.J. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene 23 (2004) 883-893
12. Hobbs S.S., Gallo R.M., and Riese II D.J. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta. Growth Factors 23 (2005) 273-283
13. Plowman G.D., Green J.M., Culouscou J.M., Carlton G.W., Rothwell V.M., and Buckley S. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366 (1993) 473-475
14. Riese II D.J., van Raaij T.M., Plowman G.D., Andrews G.C., and Stern D.F. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 15 (1995) 5770-5776
15. Riese II D.J., Bermingham Y., van Raaij T.M., Buckley S., Plowman G.D., and Stern D.F. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 12 (1996) 345-353
16. Sweeney C., Lai C., Riese II D.J., Diamonti A.J., Cantley L.C., and Carraway III K.L. Ligand discrimination in signaling through an ErbB4 receptor homodimer. J. Biol. Chem. 275 (2000) 19803-19807
17. Chung E., Graves-Deal R., Franklin J.L., and Coffey R.J. Differential effects of amphiregulin and TGF-alpha on the morphology of MDCK cells. Exp. Cell Res. 309 (2005) 149-160
18. Willmarth N.E., and Ethier S.P. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J. Biol. Chem. 281 (2006) 37728-37737
19. Gilmore J.L., Gallo R.M., and Riese II D.J. The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signaling events. Biochem. J. 396 (2006) 79-88
20. Streicher K.L., Willmarth N.E., Garcia J., Boerner J.L., Dewey T.G., and Ethier S.P. Activation of a nuclear factor kB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Mol. Cancer Res. 5 (2007) 847-861
21. Dawson J.P., Berger M.B., Lin C.-C., Schlessinger J., Lemmon M.A., and Ferguson K.M. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol. Cell. Biol. 25 (2005) 7734-7742
22. Bernfield M., Gotte M., Park P.W., Reizes O., Fitxzgerald M.L., Lincecum J., and Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
23. Ponomareva O.N., Ma H., Dakour R., Raabe T.D., Lai C., and Rimer M. Stimulation of acetylcholine receptor transcription by neuregulin-2 requires an N-box response element and is regulated by alternative splicing. Neuroscience 134 (2005) 495-503